Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Henry Q. Xiong, MD, PhD
M.D. Anderson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
Fort Smith, Arkansas, United States
- M.D. Anderson Cancer Center - Orlando
Orlando, Florida, United States
- Ccop - Atlanta Regional
Atlanta, Georgia, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Ccop - Wichita
Wichita, Kansas, United States
- Ccop - Kansas City
Kansas City, Missouri, United States
- Ccop - Cancer Research for the Ozarks
Springfield, Missouri, United States
- Ccop - Dayton
Dayton, Ohio, United States
- Ccop - Columbia River Oncology Program
Portland, Oregon, United States
- M.D. Anderson Cancer Center at University of Texas
Houston, Texas, United States
- All Saints Cancer Center at All Saints Healthcare
Racine, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2003
- Primary completion
- 31 Jul 2005
- Completion
- 31 Jul 2005
- Last update posted
- 31 Oct 2018
- Registered enrollment
- 28
- Registry id
- NCT00068432
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.